ABIVAX Société Anonyme Balance Sheet Health
Financial Health criteria checks 5/6
ABIVAX Société Anonyme has a total shareholder equity of €196.0M and total debt of €73.9M, which brings its debt-to-equity ratio to 37.7%. Its total assets and total liabilities are €327.1M and €131.1M respectively.
Key information
37.7%
Debt to equity ratio
€73.93m
Debt
Interest coverage ratio | n/a |
Cash | €260.99m |
Equity | €196.01m |
Total liabilities | €131.05m |
Total assets | €327.06m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AAVX.F's short term assets (€286.0M) exceed its short term liabilities (€70.0M).
Long Term Liabilities: AAVX.F's short term assets (€286.0M) exceed its long term liabilities (€61.0M).
Debt to Equity History and Analysis
Debt Level: AAVX.F has more cash than its total debt.
Reducing Debt: AAVX.F's debt to equity ratio has increased from 31.5% to 37.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AAVX.F has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: AAVX.F has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 31.3% each year.